InsidersTradesSigma
NRC HEALTH Stock: price and directors' dealings · United States · SEC (Form 4)
Track the NRC HEALTH stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Market capitalisation: €504.8m. The latest transaction was disclosed on 25 June 2026 (Attribution). Among the most active insiders: Berwick Donald M. All data is accessible without an account.
5
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate NRC HEALTH Buy (bullish), based on 1 analysts. Average price target: US$23.00.
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 10,599 of 25,936 companies
56.7
score / 100
Value43
Quality71
FCF yld3.2%
Earn yld2.3%
EV/EBITDA18.8x
ROE42%
Gross mgn62%
Net mgn8.2%
Debt/EBITDA2.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 25 June 2026
Declarations5 total
7,697 sharesCommon StockSEC:0001008886-26-000189:0
7,697 sharesCommon StockSEC:0001008886-26-000188:0
7,697 sharesCommon StockSEC:0001008886-26-000185:0
7,697 sharesCommon StockSEC:0001008886-26-000186:0
7,697 sharesCommon StockSEC:0001008886-26-000187:0
5 of 5 declarations
About NRC HEALTH
NRC Health is a company specializing in the collection and analysis of healthcare data. It helps organizations enhance patient experience and optimize healthcare facility performance.